BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bernardino I, Dionísio A, Castelo-Branco M. Cortical inhibition in neurofibromatosis type 1 is modulated by lovastatin, as demonstrated by a randomized, triple-blind, placebo-controlled clinical trial. Sci Rep 2022;12:13814. [PMID: 35970940 DOI: 10.1038/s41598-022-17873-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Durrani S, Mualem W, Shoushtari A, Nathani KR, Bydon M. Mapping the Landscape of Neurofibromatosis: A Bibliometric Evaluation Highlighting Our Current Understanding, Emerging Therapies, and Global Research Trends. World Neurosurg 2022;167:e1345-53. [PMID: 36108912 DOI: 10.1016/j.wneu.2022.09.032] [Reference Citation Analysis]